Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia.

about

Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia.

Item

http://www.wikidata.org/entity/Q36627644

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia.

@ast

Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia.

@en

type

Item

label

Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia.

@ast

Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia.

@en

prefLabel

Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia.

@ast

Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia.

@en

P1476

Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia.

@en

P2093

Chaya Kapugama

http://www.w3.org/2001/XMLSchema#string

Mohammed Al-Uzri

http://www.w3.org/2001/XMLSchema#string

Suneeta James

http://www.w3.org/2001/XMLSchema#string

P2860

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity.

Aripiprazole in schizophrenia and schizoaffective disorder: A review.

Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study

Subjective and objective quality of life in schizophrenia.

Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study.

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.

Aripiprazole for patients with schizophrenia and schizoaffective disorder: an open-label, randomized, study versus haloperidol.

Do needs, symptoms or disability of outpatients with schizophrenia influence family burden?

Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms.

P304

7912083

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2016/7912083

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

294724139

http://www.w3.org/2001/XMLSchema#string

P698

26981301

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

P932

4770118

http://www.w3.org/2001/XMLSchema#string